• AO/PI Double Staining Kit: Practical Guide for Cell Viabilit

  2026-05-05

  The AO/PI Double Staining Kit provides a rapid, reliable means to distinguish viable, apoptotic, and necrotic cells using fluorescent dyes. It is optimized for cell viability, apoptosis, and necrosis detection in diverse research contexts, but should not be used where quantitative live/dead cell enumeration or advanced mechanistic insight beyond viability/apoptosis/necrosis is required.

• TH287 MTH1 Inhibitor: Precision Control of DNA Damage Respon

  2026-05-04

  Discover how the TH287 MTH1 inhibitor advances cancer research by enabling precise experimental control over oxidative DNA damage and radiosensitization, with a focus on rigorous protocol optimization and unique mechanistic insights.

• Pepstatin A: Aspartic Protease Inhibition in Necroptosis Res

  2026-05-04

  Explore the unique utility of Pepstatin A as an aspartic protease inhibitor in dissecting the lysosomal membrane permeabilization process during necroptosis. This article delivers fresh mechanistic insights, advanced protocol guidance, and direct relevance for researchers studying regulated cell death.

• Localized Muscle BDNF and MMPs Direct Early NMJ Postsynaptic

  2026-05-03

  This study uncovers how muscle-derived BDNF, via spatially regulated trafficking and activity-dependent release, controls the earliest formation of acetylcholine receptor clusters at neuromuscular junctions. The work highlights the critical role of proteolytic BDNF conversion—specifically implicating MMPs—in orchestrating synaptic architecture, providing mechanistic and methodological foundations for future experimental targeting.

• TH287 MTH1 Inhibitor: Precision Tools for Cancer Cell Radios

  2026-05-02

  Explore the unique mechanism and advanced applications of the TH287 MTH1 inhibitor in cancer research. This article delivers in-depth scientific analysis and practical guidance on leveraging TH287 for selective radiosensitization, highlighting its distinct role compared to other approaches.

• Arachidonic Acid Enhances Vaccine-Induced Humoral Immunity i

  2026-05-01

  This study demonstrates that dietary arachidonic acid (ARA) supplementation accelerates and enhances the humoral immune response to rabies vaccination in both mice and humans. Mechanistic insights reveal ARA's role in modulating B cell activation via prostaglandin I2, highlighting nutritional modulation as a potential strategy to improve vaccine efficacy.

• Branched Endosomal Disruptor Lipids Advance mRNA Delivery in

  2026-05-01

  The referenced study introduces a new class of branched ionizable lipids (BEND) that enhance endosomal escape, enabling more efficient delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complexes into hepatic cells and T cells. These findings provide a significant advance in the optimization of lipid nanoparticle (LNP) design for gene editing and mRNA-based therapies, with important implications for both basic research and clinical translation.

• Antibody Inhibition of CD16 Shedding Enhances Tumor Immunity

  2026-04-30

  This study introduces a monoclonal antibody, F9H4, that selectively inhibits the shedding of CD16a and CD16b from immune cells, thereby amplifying antibody-dependent cellular cytotoxicity (ADCC) against tumors. The approach overcomes key limitations of broad ADAM17 inhibition, offering a substrate-targeted strategy to potentiate therapeutic antibody efficacy in cancer models.

• G-15: Precision GPR30 Antagonist for Neuropathic Pain Resear

  2026-04-30

  Discover how G-15, a selective G protein-coupled estrogen receptor antagonist, advances neuropathic pain and estrogen signaling research. This article uniquely explores G-15's role in dissecting spinal neuron function and practical assay decision-making.

• SHC-1 Inhibition Elevates CFTR Surface Levels in Epithelial

  2026-04-29

  This study elucidates how SHC-1 inhibition modulates CFTR channel abundance at the plasma membrane in diverse epithelial models. By mapping the MAPK/SHC-1 signaling pathway’s role in CFTR internalization, the research clarifies cell-type-specific dynamics relevant to cystic fibrosis and secretory epithelial disease.

• QNZ (EVP4593) in Translational Inflammation and Neurodegener

  2026-04-29

  Explore how QNZ (EVP4593), a potent NF-κB pathway inhibitor, is redefining translational approaches in inflammation and neurodegenerative disease models. This in-depth analysis integrates mechanistic insights, protocol guidance, and critical assay decisions for advanced research.

• P2Y2 Receptor Activation in Microglial Aβ Clearance: Mechani

  2026-04-28

  Kim et al. (2012) uncover that nucleotides released from Aβ1–42-stimulated microglia enhance both cell migration and Aβ uptake via P2Y2 receptor activation. This mechanism highlights a potential therapeutic target to promote amyloid clearance in Alzheimer's disease models, with implications for modulating neuroinflammation and phagocytic efficiency.

• Carbapenemase Genes in Enterobacter cloacae: Resistance Dyna

  2026-04-28

  This study provides a comprehensive analysis of carbapenemase-encoding gene prevalence, transmission, and resistance phenotypes among carbapenem-resistant Enterobacter cloacae isolates in eight teaching hospitals in Guangdong, China. The findings reveal high rates of multidrug resistance, particularly associated with the blaNDM-1 gene, and highlight the dominant role of plasmid-mediated gene transfer, offering critical insight for infection control and research on treatment strategies.

• Spleen-Targeted Neoantigen mRNA Vaccine Drives TLS in HCC

  2026-04-27

  Lin et al. (2026) introduce a spleen-targeted neoantigen mRNA vaccine that elicits robust antitumor immunity in hepatocellular carcinoma (HCC) by activating a unique ISG15+ CD8+ T cell subset and promoting tertiary lymphoid structure (TLS) formation. This work reveals mechanistic insights and potential translational avenues for immune-refractory cancers.

• RG108: DNA Methyltransferase Inhibitor for Epigenetic Modula

  2026-04-27

  RG108 enables precise, non-cytotoxic epigenetic modulation by inhibiting DNA methyltransferases, making it a valuable DNA demethylation agent for cancer research and stem cell studies. Its workflow-friendly properties and compatibility with other reprogramming strategies set it apart for robust, reproducible gene regulation assays.

15605 records 1/1041 page Next 12345 下5页 Last page